Searched for
ORAL SOLID BUSINESS
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Market bets on Aurobindo as Europe, US sales show uptickAurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Sai Parenteral's raises over Rs 122 crore from anchor investorsSai Parenteral's Ltd has raised over Rs 122 crore from anchor investors ahead of its IPO opening on March 24. The Hyderabad-based pharmaceu...
- WEF recognises DRL's Bachupally plant, Cipla's Indore OSD unit as part of Global Lighthouse NetworkA press release from the city-based drug maker said Lighthouses are factories leading the way in Fourth Industrial Revolution (Industry 4.0...
- Aurobindo Pharma restructuring to unlock value for shareholders: Vishal Manchanda“Aurobindo injectable business can trade at up to 35x valuation. Aurobindo’s current trading multiple is around 10x. So there is a large up...
- Alembic Pharma expects domestic biz to grow in double digits in the current fiscal"We completed this transition in 2019-20 and started witnessing an uptick in performance in the last quarter of the fiscal," Alembic Pharma...
- Piramal Pharma Solutions to acquire G&W Laboratories' drug manufacturing facility in USThe site has received certifications from the Food and Drug Administration (FDA) and European Medicines Agency (EMA), it added.
- USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory actionAccording to USFDA's definitions, OAI means "objectionable conditions were found and regulatory administrative sanctions by FDA are indicat...
- Buy Aurobindo Pharma, target Rs 836: Elara CapitalBuy Aurobindo Pharma Ltd. at a price target of Rs 836.
- Aurobindo Pharma acquires dermatology business from Sandoz in a $900 million cash dealThe acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities ...
- Alembic Pharma plans Rs 720-crore capex for FY19The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.
- Hold Aurobindo Pharma, target Rs 650: ICICI DirectHold Aurobindo Pharma Ltd. at a price target of Rs 650.0 .
- Cadila Healthcare extends losses; company clarifiesThe stock fell 2.97 per cent to hit a low of Rs 313.60 on BSE. This was the third day of consecutive fall for the stock.
- Glenmark to set up first manufacturing facility in USThe proposed facility would house three units to produce oral solids, injectables and topicals and begin production by the end of the curre...
- Panacea's Baddi unit gets US FDA approvalDrug maker Panacea Biotec on Friday said its pharmaceutical facility at Baddi in Himachal Pradesh has received approval from US health regu...
Load More
